Cindy Tran, MD
Internal Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Michigan State University College of Human Medicine, 2017
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A164048 · Current
Licensed to practise in California · since 2019 · expires 2027-08-31 · Michigan State University College of Human Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Original Medicare doctor bills
$65,588
Medicare paid this office $65,588 for 180 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 79 | $24,024 | $159 |
| Return visit (30+ min) | 125 | $16,801 | $103 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $13,060 | $157 |
| Transitional care management services for problem of at least moderate complexity | 14 | $3,246 | $203 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $1,330 | $15 |
See all 6 services
| Long return visit (40+ min) | 79 | $24,024 | $159 |
| Return visit (30+ min) | 125 | $16,801 | $103 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $13,060 | $157 |
| Transitional care management services for problem of at least moderate complexity | 14 | $3,246 | $203 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $1,330 | $15 |
| Short return visit (20+ min) | 12 | $849 | $71 |
Who their Medicare patients are
180 Original Medicare patients in 2024. Average age 77 · Women 64% · Also on Medicaid 13% · Health risk score 0.99. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 65% · Chronic kidney disease 25% · Depression 21% · Diabetes 19% · Coronary heart disease 18% · Cancer 18% · Atrial fibrillation 17% · COPD 9% · Dementia 9% · Heart failure 8%.
The office billed $188,534, Medicare allowed $85,367 and paid $65,588; for 558 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 180 | 558 | 77 | 0.99 | $188,534 | $65,588 |
| 2023 | 167 | 455 | 76 | 1.03 | $154,336 | $58,077 |
| 2022 | 225 | 590 | 77 | 1.11 | $184,566 | $68,492 |
| 2021 | 69 | 137 | 78 | 0.95 | $41,463 | $16,044 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 68 | $18,216 | $154 |
| Return visit (30+ min) | 112 | $16,732 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,604 | $160 |
| Transitional care management services for problem of at least moderate complexity | 14 | $3,261 | $204 |
| Short return visit (20+ min) | 24 | $1,876 | $78 |
2022: 6 services
| Return visit (30+ min) | 154 | $27,529 | $119 |
| Long return visit (40+ min) | 76 | $16,273 | $151 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 69 | $10,736 | $156 |
| Short return visit (20+ min) | 50 | $3,796 | $60 |
| New patient visit (45+ min) | 12 | $796 | $66 |
| Administration of influenza virus vaccine | 15 | $558 | $37 |
2021: 3 services
| Long return visit (40+ min) | 35 | $7,006 | $171 |
| Return visit (30+ min) | 16 | $2,349 | $124 |
| New patient visit (45+ min) | 13 | $1,932 | $149 |
Drugs they prescribed that Part D paid
$143,584
Pharmacies billed $143,584 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (40 of 1,634) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,469 generic and fewer than 11 brand-name prescriptions · $143,584 in drug cost · 37 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 18 | $19,003 | $1,056 |
| Eliquis | 22 | $12,138 | $552 |
| Atorvastatin | 168 | $1,818 | $11 |
| Losartan | 112 | $1,579 | $14 |
| Synthroid | 12 | $1,216 | $101 |
See all 38 drugs
| Ozempic | 18 | $19,003 | $1,056 |
| Eliquis | 22 | $12,138 | $552 |
| Atorvastatin | 168 | $1,818 | $11 |
| Losartan | 112 | $1,579 | $14 |
| Synthroid | 12 | $1,216 | $101 |
| Duloxetine | 27 | $900 | $33 |
| Amlodipine Besylate | 66 | $863 | $13 |
| Gabapentin | 54 | $677 | $13 |
| Albuterol Sulfate Hfa | 24 | $658 | $27 |
| Omeprazole | 59 | $628 | $11 |
| Pantoprazole | 37 | $594 | $16 |
| Metoprolol | 29 | $563 | $19 |
| Trazodone | 29 | $501 | $17 |
| Levothyroxine | 52 | $464 | $9 |
| Diclofenac | 12 | $460 | $38 |
| Rosuvastatin | 41 | $444 | $11 |
| Lisinopril | 51 | $367 | $7 |
| Ezetimibe | 13 | $353 | $27 |
| Furosemide | 41 | $307 | $7 |
| Metformin Hcl Er | 30 | $292 | $10 |
| Mirtazapine | 12 | $282 | $24 |
| Doxazosin Mesylate | 14 | $280 | $20 |
| Alendronate | 17 | $269 | $16 |
| Simvastatin | 19 | $245 | $13 |
| Pravastatin | 21 | $216 | $10 |
| Hydralazine | 14 | $181 | $13 |
| Ketoconazole | 12 | $158 | $13 |
| Hydrochlorothiazide | 33 | $153 | $5 |
| Metoprolol | 19 | $135 | $7 |
| Carvedilol | 12 | $114 | $10 |
| Hydroxyzine | 13 | $84 | $6 |
| Ondansetron Odt | 22 | $72 | $3 |
| Atenolol | 16 | $69 | $4 |
| Metformin | 15 | $69 | $5 |
| Triamcinolone Acetonide | 13 | $67 | $5 |
| Paroxetine | 11 | $49 | $4 |
| Tramadol | 18 | $30 | $2 |
| Azithromycin | 11 | $26 | $2 |
Year by year
| 2024 | 1,634 | 204 | 2% (40) | None | $143,584 |
| 2023 | 1,355 | 172 | 2% (23) | None | $67,570 |
| 2022 | 942 | 180 | 2% (17) | 11% | $64,460 |
| 2021 | 146 | 71 | None | None | $13,961 |
| 2020 | 114 | 42 | 0% (0) | None | $6,192 |
| 2019 | 130 | 54 | 0% (0) | 17% | $5,243 |
| 2018 | 18 | None | 0% (0) | None | $566 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Eliquis | 12 | $8,201 | $683 |
| Atorvastatin | 128 | $1,697 | $13 |
| Losartan | 72 | $1,520 | $21 |
| Omeprazole | 54 | $1,213 | $22 |
| Estradiol | 15 | $990 | $66 |
| Diclofenac | 15 | $891 | $59 |
| Amlodipine Besylate | 62 | $867 | $14 |
| Levothyroxine | 57 | $854 | $15 |
| Pravastatin | 33 | $607 | $18 |
| Duloxetine | 18 | $579 | $32 |
| Albuterol Sulfate Hfa | 20 | $564 | $28 |
| Tamsulosin | 19 | $547 | $29 |
| Metoprolol | 28 | $490 | $17 |
| Metformin Hcl Er | 24 | $462 | $19 |
| Trazodone | 34 | $462 | $14 |
| Rosuvastatin | 30 | $436 | $15 |
| Lisinopril | 55 | $419 | $8 |
| Furosemide | 43 | $374 | $9 |
| Pantoprazole | 27 | $346 | $13 |
| Potassium Chloride | 12 | $337 | $28 |
| Simvastatin | 24 | $312 | $13 |
| Paroxetine | 18 | $308 | $17 |
| Hydralazine | 15 | $308 | $21 |
| Metformin | 14 | $264 | $19 |
| Metoprolol | 17 | $254 | $15 |
| Gabapentin | 24 | $245 | $10 |
| Alendronate | 12 | $234 | $19 |
| Fosinopril | 12 | $211 | $18 |
| Carvedilol | 18 | $182 | $10 |
| Atenolol | 15 | $137 | $9 |
| Hydroxyzine | 12 | $135 | $11 |
| Hydrochlorothiazide | 17 | $104 | $6 |
| Ondansetron Odt | 15 | $57 | $4 |
2022: 26 drugs
| Rosuvastatin | 25 | $1,090 | $44 |
| Atorvastatin | 65 | $803 | $12 |
| Levothyroxine | 27 | $641 | $24 |
| Diclofenac | 16 | $604 | $38 |
| Albuterol Sulfate Hfa | 16 | $599 | $37 |
| Omeprazole | 33 | $545 | $17 |
| Losartan | 42 | $486 | $12 |
| Pantoprazole | 20 | $403 | $20 |
| Amlodipine Besylate | 43 | $339 | $8 |
| Trazodone | 22 | $317 | $14 |
| Metoprolol | 16 | $297 | $19 |
| Furosemide | 29 | $284 | $10 |
| Lisinopril | 26 | $284 | $11 |
| Potassium Chloride | 12 | $267 | $22 |
| Pravastatin | 19 | $258 | $14 |
| Carvedilol | 11 | $247 | $22 |
| Paroxetine | 13 | $207 | $16 |
| Tamsulosin | 16 | $174 | $11 |
| Duloxetine | 13 | $164 | $13 |
| Paxlovid (Eua) | 14 | $140 | $10 |
| Lovastatin | 12 | $122 | $10 |
| Atenolol | 18 | $106 | $6 |
| Cephalexin | 15 | $99 | $7 |
| Hydroxyzine | 12 | $83 | $7 |
| Simvastatin | 11 | $81 | $7 |
| Hydrochlorothiazide | 11 | $63 | $6 |
Money from drug and device companies
$37 in 2023
| 2023 | 2 | 2 | None | $37 |
| 2022 | 3 | 8 | None | $231 |
| 2020 | 1 | 1 | None | $15 |
| 2019 | 1 | 1 | None | $21 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bayer Healthcare Pharmaceuticals | Nubeqa | $19 | 1 payment
|
| Astellas Pharma US | Padcev | $18 | 1 payment
|
See all 2 published payments
| Astellas Pharma US | Meals · 2023-08-09 | Padcev | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2023-05-10 | Nubeqa | $19 |
See earlier years (2022, 2020, 2019)
2022: $231
| Allergan | Botox | $198 | 6 payments
|
| Foundation Medicine | Foundationone Cdx | $18 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $15 | 1 payment
|
2020: $15
| TerSera Therapeutics | Xermelo | $15 | 1 payment
|
2019: $21
| Dendreon Pharmaceuticals | Provenge | $21 | 1 payment
|
Professional record
- NPI
- 1073016804
- Licence
- CA A164048California A164048: Current · expires 2027-08-31
- Trained
- Michigan State University College of Human Medicine, 2017 · 9 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-03-18
- NPI last updated
- 2021-11-01
- NPI record certified
- 2021-11-01
This is when the NPI record was last certified, not a medical board exam.